Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio
Market Indicators
Chart for Dow Jones Industrial Average (DJI: DJI) Chart for Dow Jones Industrial Average (DJI: DJI)
Index Price Change % Change
DJI DAILY 21,394.76
-2.53
-0.01%
S&P 500  2,438.30
+3.80
+0.16%
Nasdaq DAILY 6,265.25
+28.56
+0.46%
Gold RT 1,257.80
+8.40
+0.67%
Oil RT 43.17
+0.43
+1.01%
10Y Yield DAILY 2.143
-0.00
-0.23%
Sectors
More Sectors
Sector % Change YTD %
Basic Materials Sector 
+0.59%
-1.50%
Conglomerates Sector 
+0.09%
-0.08%
Consumer Goods Sector 
+0.60%
+2.96%
Financial Sector 
+1.70%
+1.83%
Healthcare Sector 
+0.37%
+24.16%
Industrial Goods Sector 
+0.69%
+9.70%
Services Sector 
+0.31%
+4.63%
Technology Sector 
+4.74%
+20.90%
Utilities Sector 
+0.04%
+7.86%
Currencies
More Currencies
flag more Euro to Dollar
1 to 1.1193
 more flag
flag more Dollar to Yen
1 to 111.2805
 more flag
flag more GBP to Dollar
1 to 1.2797
 more flag
flag more Dollar to CAD
1 to 1.3275
 more flag
World Markets
More
Index Price Change % Change
flag FTSE 7,424.13
-15.16
-0.20%
flag CAC 5,266.12
-15.81
-0.30%
flag DAX 12,733.41
-60.59
-0.47%
flag NIKKEI 20,132.67
+22.16
+0.11%
flag HSI 25,670.05
-4.48
-0.02%
flag ASX 5,754.60
+12.30
+0.21%
flag S&P/TSX 15,319.56
+99.66
+0.65%
Market Summary
Previous
Higher close as crude oil edges up
Crude oil prices edged up again to lift the markets to a higher close with the Dow slipping 2 points to 21,394. Nasdaq climbed 28 points to 6,265. Read More
TICKERS  ASIX COMP DJI EQT
Stocks
More News
FDA approves Portola's Bevyxxa
The Food and Drug Administration approved Portola Pharmaceuticals Inc.'s (Nasdaq: PTLA) blood clot prevention drug Bevyxxa. Shares of the company surged $17.81 to close at $56.06.... Read More
TICKERS  PTLA
Coverage initiated on AdvanSix
Cowen initiated coverage of AdvanSix Inc. (NYSE: ASIX) with an Outperform rating sending the stock price soaring $2.83 to close at $32.85.... Read More
TICKERS  ASIX
Ocular Therapeutix names new CEO
Ocular Therapeutix Inc. (Nasdaq: OCUL) named Antony Mattessich as its next chief executive. The stock price plunged $1.39 to close at $10.15.... Read More
TICKERS  OCUL
Bed Bath & Beyond disappoints
Bed Bath & Beyond Inc. (Nasdaq: BBBY) disappointed with sharply lower first quarter earnings of 53 cents per share compared with 80 cents per share in the year ago period that missed expectations by a... Read More
TICKERS  BBBY
BlackBerry revenue falls short
BlackBerry Ltd. (Nasdaq: BBRY) reported first quarter revenue that fell short of analyst expectations. The stock price dropped $1.35 to close at $9.71.... Read More
TICKERS  BBRY
Synchronoss Technologies receives unsolicited bid
Synchronoss Technologies Inc. (Nasdaq: SNCR) received an unsolicited acquisition offer from Siris Capital Group for a premium of $18.00 per share in cash sending the stock price soaring $4.06 to close... Read More
TICKERS  SNCR
Altice surges in debut
Shares of Altice USA Inc. (NYSE: ATUS) surged $2.71 to close at $32.71 on its first trading day... Read More
TICKERS  ATUS
Jernigan Capital prices offering at discount
Jernigan Capital Inc. (NYSE: JCAP) priced its upsized public offering of 3.5 million common shares at the discounted price of $22.00 per share sending the stock price tumbling $1.94 to close at... Read More
TICKERS  JCAP
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial